Kathrin Schmidt

Project Manager Non-Interventional Studies
Bayer, Berlin, Germany
Berlin, Berlin, Germany

Presentation(s):

• PB0261 - Investigating effectiveness and safety of extended dosing regimens of damoctocog alfa pegol in the real-world HEM-POWR study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT